153 related articles for article (PubMed ID: 6189139)
1. Maprotiline in the treatment of endogenous depression: comparison of therapeutic effect with serotonin level in blood platelets.
Mück-Seler D; Deanović Z; Jamnicky B; Jakupcević M; Mihovilović M
Psychopharmacology (Berl); 1983; 79(2-3):262-5. PubMed ID: 6189139
[TBL] [Abstract][Full Text] [Related]
2. A double-blind comparative clinical trial of citalopram vs maprotiline in hospitalized depressed patients.
Timmerman L; de Beurs P; Tan BK; Leijnse-Ybema H; Sanchez C; Høpfner Petersen HE; Cohen Stuart MH
Int Clin Psychopharmacol; 1987 Jul; 2(3):239-53. PubMed ID: 2447151
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and biochemical contributions on the effect of maprotiline and clomipramine in depressive states (preliminary observation)].
Ravizza L
Psychiatr Clin (Basel); 1979; 12(3):164-72. PubMed ID: 94169
[TBL] [Abstract][Full Text] [Related]
4. Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients.
Mück-Seler D; Jakovljević M; Deanović Z
J Affect Disord; 1991 Nov; 23(3):157-64. PubMed ID: 1774431
[TBL] [Abstract][Full Text] [Related]
5. Uptake of 5-hydroxytryptamine and dopamine into platelets from depressed patients and normal subjects--influence of clomipramine, desmethylclomipramine and maprotiline.
Ehsanullah RS
Postgrad Med J; 1980; 56 Suppl 1():31-5. PubMed ID: 7393826
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic superiority of maprotiline versus doxepin in geriatric depression.
Gwirtsman HE; Ahles S; Halaris A; DeMet E; Hill MA
J Clin Psychiatry; 1983 Dec; 44(12):449-53. PubMed ID: 6361005
[TBL] [Abstract][Full Text] [Related]
7. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. Biochemical aspects.
Nyström C; Ross SB; Hällström T; Kelder D
Acta Psychiatr Scand; 1986 Feb; 73(2):133-8. PubMed ID: 2939691
[TBL] [Abstract][Full Text] [Related]
8. Plasma tryptophan and tyrosine ratios to competing amino acids in relation to antidepressant response to citalopram and maprotiline. A preliminary study.
Møller SE; de Beurs P; Timmerman L; Tan BK; Leijnse-Ybema HJ; Stuart MH; Petersen HE
Psychopharmacology (Berl); 1986; 88(1):96-100. PubMed ID: 3080781
[TBL] [Abstract][Full Text] [Related]
9. Platelet serotonin in essential hypertension and in mental depression.
Baudouin-Legros M; Le Quan-Bui KH; Guicheney P; Kamal LA; Meyer P
J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S12-4. PubMed ID: 2412030
[TBL] [Abstract][Full Text] [Related]
10. Maprotiline in affective illness. Plasma concentration and clinical response.
Norman TR; Burrows GD; Maguire KP; McIntyre IM; Scoggins BA
J Affect Disord; 1983 May; 5(2):147-54. PubMed ID: 6222094
[TBL] [Abstract][Full Text] [Related]
11. Lithium addition in antidepressant-resistant depression: effects on platelet 5-HT, plasma 5-HT and plasma 5-HIAA concentration.
Birkenhäger TK; van den Broek WW; Fekkes D; Mulder PG; Moleman P; Bruijn JA
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1084-8. PubMed ID: 17467132
[TBL] [Abstract][Full Text] [Related]
12. Plasma free 3-methoxy-4-hydroxyphenylglycol predicts response to fluoxetine.
Ko HC; Lu RB; Shiah IS; Hwang CC
Biol Psychiatry; 1997 Apr; 41(7):774-81. PubMed ID: 9084896
[TBL] [Abstract][Full Text] [Related]
13. Comparison between a serotonin and a noradrenaline reuptake blocker in the treatment of depressed outpatients. A cross-over study.
Nyström C; Hällström T
Acta Psychiatr Scand; 1987 Apr; 75(4):377-82. PubMed ID: 3035878
[TBL] [Abstract][Full Text] [Related]
14. Serotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activity.
Celada P; Sarrias MJ; Artigas F
J Neural Transm Suppl; 1990; 32():149-54. PubMed ID: 1708403
[TBL] [Abstract][Full Text] [Related]
15. Platelet 5-HT(1A) receptor correlates with major depressive disorder in drug-free patients.
Zhang ZJ; Wang D; Man SC; Ng R; McAlonan GM; Wong HK; Wong W; Lee J; Tan QR
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Aug; 53():74-9. PubMed ID: 24657886
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the effects of maprotiline (ludiomil) and clomipramine (anafranil) on serotonin uptake and tryptophan-binding in plasma.
Greengrass PM; Waldmeier PC; Imhof PR; Maitre L
Biol Psychiatry; 1976 Feb; 11(1):91-100. PubMed ID: 1260079
[TBL] [Abstract][Full Text] [Related]
17. Does platelet serotonin receptor supersensitivity accompany endogenous depression?
Brusov OS; Beliaev BS; Katasonov AB; Zlobina GP; Factor MI; Lideman RR
Biol Psychiatry; 1989 Feb; 25(4):375-81. PubMed ID: 2930807
[TBL] [Abstract][Full Text] [Related]
18. Maprotiline versus imipramine and placebo in neurotic depression.
van der Velde CD
J Clin Psychiatry; 1981 Apr; 42(4):138-41. PubMed ID: 7009592
[TBL] [Abstract][Full Text] [Related]
19. [Clinical and biochemical contributions on the action of maprotiline and clomipramine in depressive states (preliminary observation)].
Ravizza L
Psychiatr Clin (Basel); 1979; 13(3):164-72. PubMed ID: 93762
[TBL] [Abstract][Full Text] [Related]
20. Effects of the antidepressant drug tianeptine on plasma and platelet serotonin of depressive patients and healthy controls.
Ortiz J; Mariscot C; Alvarez E; Artigas F
J Affect Disord; 1993 Dec; 29(4):227-34. PubMed ID: 7510316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
